Malin Corp. PLC

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Ireland's Altan Pharma believes that the US is still the land of opportunity and is targeting the country's $300m market for intravenous formulations of paracetamol to take the privately held firm to

Ex- Zealand Pharma AS head David Horn Solomon is joining Silence Therapeutics PLC as its new CEO, effective immediately. Previously, Solomon was the CEO of Bionor Pharma ASA and Akari Therap

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bioph